REDWOOD-HCM, SEQUOIA-HCM and FOREST-HCM trials: Incidence and impact of atrial fibrillation in oHCM with aficamten
31 August 2025 (16:45 - 17:00)
Organised by: 
Slides
About the speaker
Oregon Health & Science University Medical Group, Portland (United States of America)
3 More presentations in this session
Professor C. Miller (Manchester, GB)
Access the full session
The Event
ESC Congress 2025
31 August 2025
16:45 CET
You may be interested in
Congress Session
Congress Session
